Every serving. No expiration date. Page 2 of 6.
Six hospitals changed everyday anesthesia practice, lowering estimated emissions and anesthetic spending without worsening tracked outcomes.
The study will test whether clearing amyloid, then adding a second mechanism, can delay inherited Alzheimer's.
The first Afia Birago's puddle frogs ever born under human care are now hopping at London Zoo.
The instant discount is reaching first-time electric-car buyers at the dealership.
Reported malaria deaths fell from 3,259 in 2011 to 52 in 2025.
A randomized trial found continuous glucose monitoring added about five hours a day in the target range—even without insulin.
An EMA committee recommended a once-daily oral RAS inhibitor for eligible adults with metastatic pancreatic cancer.
Eight complete responses. Twelve patients.
The future changed 2.2 million times.
A pipe budget can become a heat pump.
A school challenge has engaged 3,500+ young people in 23 countries to redesign everyday plastic use.
A 32-person study found less injury and fewer symptoms—but it is still early.
Post-harvest pond water is getting a second job on farms and wetlands.
A monitor improved when patients could explain what its sensors got wrong.
Nine hundred thirty-nine completed rehabilitations turned underused historic buildings back into homes, businesses, workplaces and community spaces while supporting an estimated 163,000 jobs.
A new WHO review says transmission now remains only in the remote cross-border Yanomami Focus Area shared by Brazil and Venezuela.
In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.
More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.
Battery installations jumped 52% from the previous half-year while households added a record 1,894 MW of rooftop solar.
The 2026 count was the highest in Georgia’s statewide record. The long-run nesting trend has risen about 4% a year since the early 1990s.
Three mother-and-young pairs and two adolescent males passed health checks before being released into a protected 23,000-hectare forest.
A preclinical formulation held onto its biological activity for more than two months at 37°C—and matched fresh material in mouse immune-response tests.
The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.
Demand broke records. The emergency alerts did not arrive. Since 2023, Texas added 19.5 GW of solar and 16 GW of battery storage.